Eric Lefkofsky has seen firsthand the ravages of cancer and the technological shortcomings of the medical establishment which is trying to fight it. New and innovative ways to track the data inherent to cancer patients is something that is near and dear to Eric Lefkofsky’s heart. This is what spurred him to co-found Tempus, a new business venture which seeks to streamline the process in which data on cancer patients is collected, accessed, and analyzed.
Tempus has designed proprietary software which can actually analyze both clinical and molecular data that oncologists provide. Not only is this a saving grace in regards to time spent by analysts, but it provides a much more clear picture as to just what is going on inside the patient themselves.
Among the hospitals that Tempus is currently partnered with are the Mayo Clinic, University of Michigan, the Cleveland Clinic, and Duke University School of Medicine. Even with the advent of Electronic Medical Records, cutting-edge technology has not exactly permeated the way that information is collected and utilized within even the top medical centers in the United States. Tempus seeks to change all of that.
Eric Lefkofsky has been an entrepreneur almost since the onset of his career. He was at the very forefront of several early Internet start-ups and has been a key figure in many modern ones. He is known throughout the industry as a very generous donor to charities, especially those that concern children. In fact, he and his wife have even seen fit to join with The Giving Pledge, an informal collective of global billionaires whose purpose it is to share some of their immense wealth with leading charities both in their lives and after their deaths. To know about him click here.
Truly, Eric Lefkofsky knows what he is doing when it comes to business and this is why so many are excited by his current undertaking. If Eric Lefkofsky has his way, his technological breakthroughs will be a boon to cancer research for years to come. If past actions are any evidence, cancer has a new enemy, and his name is Eric Lefkofsky.